Antivirals in the context of HIV disease

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. B, 1996, Pages 97-112

  Wood, M J ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR;

CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG DELIVERY SYSTEM; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPPORTUNISTIC INFECTION; PROPHYLAXIS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029809631     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_b.97     Document Type: Conference Paper

References (93)

1. Anand, R., Nightingale, S. D., Fish, R. H., Smith, T. J. & Ashton, P. (1993). Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Archives of Ophthalmology 111, 223-7.
2. Anderson, V. M. & Lee, H. (1988). Lymphocytic interstitial pneumonitis in pediatric AIDS. Pediatric Pathology 8, 417-21.
3. Andersson, J. P. (1991). Clinical aspects on Epstein-Barr virus infection. Scandinavian Journal of Infectious Diseases, Suppl. 80, 94-104.
4. Asano, Y., Yoshikawa, T., Suga, S., Kobayashi, I., Nakashima, T., Yazaki, T. et al. (1993). Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92, 219-22.
5. Balfour, H. H., Benson, C., Braun, J., Cassens, B., Erice, A., Friedman-Kien, A. et al. (1994). Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. Journal of Acquired Immunodeficiency Syndromes 7, 254-60.
6. Barbera, J. A., Hayashi, S., Hegele, R. G. & Hogg, J. C. (1992). Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. American Review of Respiratory Diseases 145, 940-6.
7. Barr, C. E., Lopez, M. R., Rua-Dobles, A., Miller, L. K., Mathur-Wagh, U. & Turgeon, L. R. (1992). HIV-associated oral lesions immunologie, virologie and salivary parameters. Journal of Oral Pathology and Medicine 21, 295-8.
8. Beral, V., Peterman, T., Berkelman, R. & Jaffe, H. (1991). AIDS associated non-Hodgkin lymphoma. Lancet 337, 805-9.
9. Birch, C. J., Tachedjian, G., Doherty, R. R., Hayes, K. & Gust, I. D. (1990). Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. Journal of Infectious Diseases 162, 731-4.
10. Buchbinder, S. P., Katz, M. H., Hessol, N. A., Lill, J. Y., O'Malley, P. M., Underwood, R. et al. (1992). Herpes zoster and human immunodeficiency virus infection. Journal of Infectious Diseases 166, 1153-6.
11. Buhles, W. C., Mastre, B. J., Tinker, A. J., Strand, V. & Koretz, S. H. (1988). Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Reviews of Infectious Diseases 10, Suppl. 3 , S495-506.
12. Cantrill, H. L., Henry, K., Melrow, N. H., Knobloch, W. H., Ramsay, R. C. & Balfour, H. H. (1989). Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long term results. Ophthalmology 96, 367-74.
13. Chatis, P. A. & Crumpacker, C. S. (1992). Resistance of herpesviruses to antiviral drugs. Antimicrobial Agents and Chemotherapy 346, 1589-95.
14. Chrisp, P. & Crissold, S. P. (1991). Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41, 104-29.
15. Cohen, P. R. & Grossman, M. E. (1989). Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection - a review of the literature. Clinical and Experimental Dermatology 14, 273-6.
16. Collins, P. & Ellis, N. M. (1993). Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. Journal of Medical Virology, Suppl. 1, 58-66.
17. Conant, M. A. & Wood, M. J., Eds (1995). Management Strategies in Herpes; Herpes Virus and HIV Infection - Co-factors and Opportunistic Injections. PPS Europe, Worthing.
18. Cooper, D. A., Gazzard, B. G., Stevens, J. & Bell, A. R. (1994). The effect of acyclovir cotherapy on survival in individuals with advanced HIV disease. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 1994. p. 61. American Society of Microbiology, Washington, DC.
19. Cooper, D. A., Pehrson, P. O., Pederson, C., Moroni, M., Oksenhendler, E., Rozenbaum, W. et al. (1993). The efficacy and safety of zidovudine alone or as cotherapy with acyclovir in the treatment of patients with AIDS and AIDS-related complex: a double-blind, randomized trial. AIDS 7, 197-207.
20. Corbellino, M., Lusso, P., Gallo, R. C., Parravicini, C., Galli, M. & Moroni, M. (1993). Disseminated human herpesvirus 6 infection in AIDS. Lancet 342, 1242.
21. Datta, A. K., Colby, B. M., Shaw, J. E. & Pagano, J. S. (1980). Acyclovir inhibition of Epstein-Barr virus replication. Proceedings of the National Academy of Sciences USA 77, 5163-6.
22. De Clercq, E. (1993). Therapeutic potential of HPMPC as an antiviral drug. Reviews in Medical Virology 3, 85-96.
23. Dehne, K. L., Dhlakama, D. G., Richter, C., Mawadza, M., McClean, D. & Huss, R. (1992). Herpes zoster as an indicator of HIV infection in Africa. Tropical Doctor 22, 68-70.
24. Dhillon, B. (1994). The management of cytomegalovirus retinitis in AIDS. British Journal of Ophthalmology 78, 66-9.
25. Diaz-Llopis, M., Chipont, E., Sanchez, S., Espana, E., Navea, A. & Menezo, J. L. (1992). Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. American Journal of Ophthalmology 114, 742-7.
26. Dieterich, D. T., Kotler, D. P., Busch, D. F., Crumpacker, C., Du Mond, C., Dearmand, B. et al. (1993). Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study. Journal of Infectious Diseases 167, 278-82.
27. Drew, W. L., Buhles, W. & Erlich, K. S. (1992). Management of herpes virus infections (CMV, HSV, VZV). In The Medical Management of AIDS, 3rd edn (Sande, M. A. & Volberding, P. A. Eds), pp. 359-82. W. B. Saunders, Philadelphia.
28. Drew, W. L., Miner, R. C., Busch, D. F., Follansbee, S. E., Gullett, J., Mehalko, S. G. et al. (1991). Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. Journal of Infectious Diseases 163, 716-9.
29. Englund, J. A., Zimmermann, M. E., Swierkosz, E. M., Goodman, J. L., Scholl, D. R. & Balfour, H. H. (1990). Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Annals of Internal Medicine 112, 416-22.
30. Erlich, K. S., Mills, J., Chatis, P., Mertz, G. J., Busch, D. F., Follansbee, S. E. et al. (1989). Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 320, 293-6.
31. Friedman-Kien, A. E., Lafleur, F. L., Gendler, E., Hennessey, N. P., Montagna, R., Halbert, R. et al. (1986). Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. Journal of the American Academy of Dermatology 14, 1023-28.
32. Gallant, J. E., Moore, R. D., Richman, D. D., Keruly, J. & Chaisson, R. E. (1992). Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. Journal of Infectious Diseases 166, 1223-7.
33. Glasby, M. J., Moore, R. D. & Chaisson, R. E. (1993). Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Journal of Infectious Diseases 168, 1264-8.
34. Goldberg, L. H., Kaufman, R. H., Kurtz, T. O., Conant, M. A., Eron, L. J., Batenhorst, R. L. et al. (1993). Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovir. Journal of Medical Virology, Suppl. 1, 45-50.
35. Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V. et al. (1986). Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313, 1564-71.
36. Griffiths, P. (1993). Management of Herpes in Immunocompromised Patients: Focus on HIV Disease. Colwood House Medical Publications, Reading.
37. Griffiths, P. D. (1995). A proposal that herpesviruses are cofactors in HIV disease. Antiviral Chemistry and Chemotherapy 6, Suppl. 1, 17-21.
38. Hardy, W. D. (1992). Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results in a controlled, randomized, regimen-comparative trial. American Journal of Medicine 92, Suppl. 2A, 30-5.
39. Heng, M. C., Heng, S. Y. & Allen, S. G. (1994). Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343, 255-8.
40. Henle, W., Henle, G., Andersson, J., Ernberg, I., Klein, G., Horwitz, C. A. et al. (1987). Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proceedings of the National Academy of Science of the United States of America 84, 570-5.
41. Hessol, N. A., Katz, M. H., Liu, J. Y., Buchbinder, S. P., Rubino, C. J. & Holmberg, S. D. (1992). Increased incidence of Hodgkin disease in homosexual men with HIV infection. Annals of Internal Medicine 117, 309-11.
42. Holland, N. P., Power, C., Mathews, V. P., Glass, J. D., Forman, M. & McArthur, J. (1994). Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 44, 507-14.
43. Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R. et al. (1993). Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. New England Journal of Medicine 329, 1922-6.
44. Huang, Y. Q., Li, J. J., Kaplan, M. H., Poiesz, B., Katabira, E., Zhang, W. C. et al. (1995). Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345, 759-61.
45. Irwin, D. & Kaplan, L. (1993). Clinical aspects of HIV-related lymphoma. Current Opinion in Oncology 5, 852-60.
46. Jabs, D. A., Enger, C. & Bartlett, J. G. (1989a). Cytomegalovirus retinitis in acquired immunodeficiency syndrome. Archives of Ophthalmology 107, 75-80.
47. Jabs, D. A., Green, W. R., Fox, R., Polk, B. F. & Bartlett, J. G. (1989b). Ocular manifestations of acquired immune deficiency syndrome. Opthalmology 96, 1092-9.
48. Jacobson, M. A., Berger, T. G., Fikrig, S., Becherer, P., Moohr, J. W., Stanat, S. C. et al. (1990). Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 112, 187-91.
49. Jura, E., Chadwick, E. G., Josephs, S. H., Steinberg, S. P., Yogev, R., Gershon, A. A. et al. (1989). Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatric Infectious Disease Journal 8, 586-90.
50. Katlama, C., Dohin, E., Caumes, E., Cochereau-Massin, I., Brancon, C., Robinet, M. et al. (1992). Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimes. Journal of Acquired Immunodeficiency Syndromes 5, Suppl. 1, 18-24.
51. Katz, E., Rosenblat, O. & Pisanty, S. (1992). Isolation and characterization of herpes simplex virus resistant to nucleoside analogs. Oral Surgery, Oral Medicine and Oral Pathology 72, 296-9.
52. Kelley, R., Mancao, M., Lee, F., Sawyer, M., Nahmias, A. & Nesheim, S. (1994). Varicella in children with perinatally acquired human immunodeficiency virus infection. Journal of Pediatrics 124, 271-3.
53. Knox, K. K. & Carrigan, D. R. (1994). Disseminated active HHV-6 infections in patients with AIDS. Lancet 343, 577-8.
54. Lalezari, J. P., Drew, W. L., Glutzer, E., James, C., Miner, D., Flaherty, J. et al. (1994). (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. Journal of Infectious Diseases 171, 788-96.
55. Leobovitz, E., Cooper, D., Giurgiutiu, D., Coman, G., Straus, I., Orlow, S. J. et al. (1993). Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus. Pediatrics 92, 838-42.
56. Markham, A. & Faulds, D. (1994). Ganciclovir, and update of its therapeutic use in cytomegalovirus infections. Drugs 48, 455-84.
57. Marks, G. L., Nolan, P. E., Erlich, K. S. & Ellis, M. N. (1989). Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Reviews of Infectious Diseases 11, 474-6.
58. Martin, D. F., Parks, D. J., Mellow, S. D., Ferris, F. L., Walton, R. C., Remaly, N. A. et al. (1994). Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Archives of Ophthalmology 112, 1531-9.
59. Mayers, D., Erice, A., Lane, J., McCutchan, F., Jabs, D., Tudor-Williams, G. et al. (1993). Foscarnet (FOS) resistant HIV isolates emerge during extended FOS therapy for CMV retinitis. In Program and Abstracts of the Thirty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 1993. p. 314. American Society of Microbiology, Washington, DC.
60. Mindel, A., Faherty, A., Carney, O., Patou, G., Freris, M. & Williams, P. (1988). Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet i, 926-8.
61. Morfeldt, L. & Torssander, J. (1994). Longterm remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scandinavian Journal of Infectious Diseases 26, 749-52.
62. Moulignier, A., Pialoux, G., Dega, H., Dupont, B., Huerre, M. & Baudrimont, M. (1995). Brain stem encephalitis due to varicella-zoster virus in a patient with AIDS. Clinical Infectious Diseases 20, 1378-80.
63. Nerurkar, L. S., Biggar, R. J., Goedert, J. J., Wallen, W., Becker, P., West, F. et al. (1987). Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage. Journal of Medical Virology 21, 123-35.
64. Palestine, A. G., Polis, M. A., DeSmet, M. D., Baird, B. F., Falloon, J., Kovacs, J. A. et al. (1991). A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Annals of Internal Medicine 115, 665-73.
65. Patterson, L. E., Butler, K. M. & Edwards, M. S. (1989). Clinical herpes zoster shortly following primary varicella in two HIV-infected children. Clinical Pediatrics 28, 354.
66. Pepose, J. S., Holland, G. N., Nestor, M. S., Cochran, A. J. & Foos, R. Y. (1985). Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology 92, 472-84.
67. Pillay, D., Lipman, M. C., Lee, C. A., Johnson, M. A., Griffiths, P. D. & McLaughlin, J. E. (1993). A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS 7, 969-74.
68. Reynolds, P., Saunders, L. D., Layefsky, M. E. & Lemp, G. F. (1993). The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. American Journal of Epidemiology 137, 19-30.
69. Ringden, O., Lönnqvist, B., Paulin, T., Ahlén, J., Klintmalm, G., Wahren, B. et al. (1986). Pharmacokinetics and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. Journal of Antimicrobial Chemotherapy 17, 373-87.
70. Safrin, S., Crumpacker, C., Chatis, P., Davis, R., Hafner, R., Rush, J. et al. (1991). A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. New England Journal of Medicine 325, 551-5.
71. Schooley, R. T. (1990). Cytomegalovirus in the setting of infection with human immunodeficiency virus. Reviews of Infectious Diseases 12, Suppl. 7, 811-9.
72. Shepp, D. H., Newton, B. A., Dandliker, P. S., Flournoy, N. & Meyers, J. D. (1985). Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. Annals of Internal Medicine 102, 783-5.
73. Snoeck, R., Andrei, G., Gérard, M., Silverman, A., Hedderman, A., Balzarini, J. et al. (1994a). Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clinical Infectious Diseases 18, 570-8.
74. Snoeck, R., Gérard, M., Sadzot-Delvaux, C., Andrei, G., Balzarini, J., Reyman, D. et al. (1994b). Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. Journal of Medical Virology 42, 338-47.
75. Squires, K. E., Stempien, M. J., Shadman, A. & Buhles, W. C. (1995). Oral ganciclovir (POG) vs IV ganciclovir (IVG) maintenance therapy for CMV retinitis in patients with AIDS: preliminary results of a phase III study. In Proceedings of the First National Conference on Human Retroviruses and Related Infections, Washington, DC, 1993.
76. Srugo, I., Israele, V., Wittek, A. E., Courville, T., Vimal, V. M. & Brunell, P. A. (1993). Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. American Journal of Diseases of Childhood 147, 742-5.
77. Stein, D. S., Graham, N. M., Park, L. P., Hoover, D. R., Phair, J. P., Detels, R. et al. (1994). The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Annals of Internal Medicine 121, 100-8.
78. Stellbrink, H. J., Albrecht, H., Loning, T. & Greten, H. (1991). Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient: successful treatment with foscarnet. Klinisch Wochenschrift 69, 274-8.
79. Studies of the Ocular Complications of AIDS Research Group, in Collaboration with the AIDS Clinical Trials Group. (1992). Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. New England Journal of Medicine 326, 213-20.
80. Studies of the Ocular Complications of AIDS Research Group, in Collaboration with the AIDS Clinical Trials Group. (1994). Foscarnet-ganciclovir cytomegalovirus trial. Ophthalmology 101, 1250-61.
81. Telzak, E. E., Chiasson, M. A., Bevier, P. J., Stoneburner, R. L., Castro, K. G. & Jaffe, H. W. (1993). HIV-1 seroconversion in patients with and without genital ulcer disease. Annals of Internal Medicine 115, 1181-6.
82. The Oral Ganciclovir European and Australian Cooperative Study Group. (1995). Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 9, 471-7.
83. Tovo, P. A., de Martino, M., Gabiano, C., Cappello, N., D'Elia, R., Loy, A. et al. (1992). Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 339, 1249-53.
84. Trang, J. M., Kidd, L., Gruber, E., Storch, G., Demmber, G., Jacobs, R. et al. (1993). Linear single dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology and Therapeutics 53, 15-21.
85. Ussery, F. M., Gibson, S. R., Conklin, R. H., Piot, D. F., Stool, E. W. & Conklin, A. J. (1989). Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology 95, 640-8.
86. Verroust, F., Lemay, D. & Laurian, Y. (1987). High frequency of herpes zoster in young hemophiliacs. New England Journal of Medicine 316, 166-7.
87. Wasserheit, J. N. (1992). Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sexually Transmitted Diseases 19, 61-77.
88. Webster, A., Lee, C. A., Cook, D. G., Grundy, J. E., Emery, V. C., Kernoff, P. B. et al. (1989). Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet ii, 63-6.
89. Wiley, C. A. & Nelson, J. A. (1988). Role of human immunodeficeincy virus and cytomegalovirus in AIDS encephalitis. American Journal of Pathology 133, 73-81.
90. Wood, M. J. (1994). Infections and the retina. In: Clinical Retinopathies (Dodson, P. M., Gibson, J. M. & Kritzinger, E. E., Eds), pp. 107-28. Chapman & Hall, London.
91. Youle, M. S., Gazzard, B. G., Johnson, M. A., Cooper, D. A., Hoy, J. F., Busch, H. et al. (1994). Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. AIDS 8, 641-9.
92. Young, S. H., Morlet, N., Heery, S., Hollows, F. C. & Coroneo, M. T. (1992). High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis. Medical Journal of Australia 157, 370-3.
93. Zurlo, J. J., O'Neill, D., Polis, M. A., Manischewitz, J., Yarchoan, R., Baseler, M. et al. (1993). Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Annals of Internal Medicine 118, 12-7.